Unplugged: Developing Standards for Wireless Automation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Unplugged: Developing Standards for Wireless Automation
ISA 100.11a and WirelessHART both seek to become the global standard for industrial wireless automation.


Pharmaceutical Technology


Profibus, Profibus International, Foundation Fieldbus, and HART have formed a working group to develop a specification that will give common interface using a wireless gateway. "We want to give users some assurance that whatever they chose [Foundation Fieldbus, Profibus, or Profinet], they are going to be able to use it going forward," says Carl Henning, deputy director at PTO, Profibus, and Profinet North America. According to Henning, the group will look at both WirelessHART and the ISA standard, although because WirelessHART is complete, Profibus has been working mainly with that standard. "I've been told that we will probably see the Profibus gateway by the end of the year. This should help users because it will result in a common interface so they won't be stuck deciding which wireless sensor network to choose."

Says Karschnia, "It seems it would be worthwhile for SP 100 to change its focus from the bit-and-byte communication sensors to bigger problem of gateways." (In a network, a sensor transmits data, the data hops through a time-synchronized mesh protocol network, and arrives at a gateway.) "ISA should focus on how does that gateway will interface to the rest of the process control systems that exists—to the DCS, to the historians, to the business systems, and to the diagnostics systems. Once someone defines that, then the industry will adopt wireless more readily. To date, Emerson has its solution, Honeywell have its solution, and everyone will have a different solution. That is where ISA can add value."

Henning offers this perspective: "The thing to remember is that it doesn't matter who puts out the standard, it's what the users adopt that is going to be important. From that standpoint, I like the idea of having competing standards. The users are winners by having competitions because the standards organizations are spurred on to do better by that competition. There is a limit, but I think with two or three competing technologies, it's a positive."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here